These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 5434836)
1. Vasodilators in prevention and treatment of ischemic stroke. Taylor JR J Iowa Med Soc; 1970 Apr; 60(4):258-61. PubMed ID: 5434836 [No Abstract] [Full Text] [Related]
7. A preliminary study of the effects of cyclandelate. Davies G Med J Aust; 1971 Feb; 1(6):313-7. PubMed ID: 4925923 [No Abstract] [Full Text] [Related]
8. [Use of hydergine in acute ischemic pathology of the brain]. Gomensoro JB Acta Neurol Latinoam; 1967; 13(1):273-82. PubMed ID: 4976823 [No Abstract] [Full Text] [Related]
9. Cerebral vasodilators. Hall P Br Med J; 1971 Aug; 3(5770):374. PubMed ID: 5558206 [No Abstract] [Full Text] [Related]
10. Cyclandelate and mental functions: a double-blind cross-over trial in normal elderly subjects. Judge TG; Urquhart A; Blakemore CB Age Ageing; 1973 May; 2(2):121-4. PubMed ID: 4591604 [No Abstract] [Full Text] [Related]
11. [The effects of vasodilators on the cerebral hemodynanics in the cerebrovascular diseases]. Furuhashi N Nihon Naika Gakkai Zasshi; 1971 Feb; 60(2):89-102. PubMed ID: 4396692 [No Abstract] [Full Text] [Related]
12. [Treatment and prevention of cerebral arterial disorders in aged and of their consequences. Rheoencephalographic examinations]. Albot G; Goutmer B; Treps J Therapeutique; 1971; 47(6):579-84. PubMed ID: 5571174 [No Abstract] [Full Text] [Related]
13. Chronic cerebrovascular disorders: a clinical study with cyclandelate. Bassi S; Albizzati MG; Sbacchi M; Frattola L Br J Clin Pract; 1984 Oct; 38(10):344-9. PubMed ID: 6498057 [No Abstract] [Full Text] [Related]
14. Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders. Albizzati MG; Bassi S; Sbacchi M; Frattola L Br J Clin Pract Suppl; 1984; 34():69-73. PubMed ID: 6430327 [No Abstract] [Full Text] [Related]
15. [Medical treatment of acute disorders of cerebral circulation]. Buscaino GA Acta Neurol Quad (Napoli); 1980; 41():74-81. PubMed ID: 7293741 [No Abstract] [Full Text] [Related]
16. [Effect of the mandelic ester of 3,5,5-trimethyl-cyclohexanol (Cyclospasmol) on blood flow potentials in peripheral obstructive arteriopathies]. Russo A; Azzolina P; Biondi M; Montemagno S; Giovinetto A Minerva Med; 1969 Aug; 60(69):3110-6. PubMed ID: 5824709 [No Abstract] [Full Text] [Related]
17. Improvement in brain oxygenation and clinical improvement in patients with strokes treated with papaverine hydrochloride. Meyer JS; Gotoh F; Gilroy J; Nara N JAMA; 1965 Nov; 194(9):957-61. PubMed ID: 5897963 [No Abstract] [Full Text] [Related]
18. The use of cyclandelate in chronic brain syndrome with arteriosclerosis. Fine EW Curr Ther Res Clin Exp; 1971 Sep; 13(9):568-74. PubMed ID: 5000458 [No Abstract] [Full Text] [Related]
19. The clinical efficacy of Cyclospasmol: a review of the literature. Blakemore CB Br J Clin Pract Suppl; 1984; 34():3-9. PubMed ID: 6430319 [No Abstract] [Full Text] [Related]
20. Electroencephalographic study of dose-response relations for cyclandelate on hyperventilation-induced vasospasm in human brain. Korenyi C; Whittier JR Angiology; 1969 Oct; 20(9):529-34. PubMed ID: 5824354 [No Abstract] [Full Text] [Related] [Next] [New Search]